EA200401617A1 - Комбинация nmda-антагониста и ингибиторов ацетилхолинэстеразы для лечения болезни альцгеймера - Google Patents

Комбинация nmda-антагониста и ингибиторов ацетилхолинэстеразы для лечения болезни альцгеймера

Info

Publication number
EA200401617A1
EA200401617A1 EA200401617A EA200401617A EA200401617A1 EA 200401617 A1 EA200401617 A1 EA 200401617A1 EA 200401617 A EA200401617 A EA 200401617A EA 200401617 A EA200401617 A EA 200401617A EA 200401617 A1 EA200401617 A1 EA 200401617A1
Authority
EA
Eurasian Patent Office
Prior art keywords
alcheimer
disease
treatment
combination
cholinesterase inhibitors
Prior art date
Application number
EA200401617A
Other languages
English (en)
Other versions
EA007632B1 (ru
Inventor
Ларс Ликке Томсен
Андерс Герсел Педерсен
Original Assignee
Х. Лундбекк А/С
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=28051666&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=EA200401617(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Х. Лундбекк А/С filed Critical Х. Лундбекк А/С
Priority claimed from PCT/DK2003/000342 external-priority patent/WO2003101458A1/en
Publication of EA200401617A1 publication Critical patent/EA200401617A1/ru
Publication of EA007632B1 publication Critical patent/EA007632B1/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/473—Quinolines; Isoquinolines ortho- or peri-condensed with carbocyclic ring systems, e.g. acridines, phenanthridines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Фармацевтическая композиция, содержащая (a) эффективное количество одного или нескольких ингибиторов ацетилхолинэстеразы или его фармацевтически эффективной соли и (b) эффективное количество одного или нескольких NMDA-антагонистов.Международная заявка была опубликована вместе с отчетом о международном поиске.
EA200401617A 2002-05-31 2003-05-22 Комбинация nmda-антагониста и ингибиторов ацетилхолинэстеразы для лечения болезни альцгеймера EA007632B1 (ru)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US38446702P 2002-05-31 2002-05-31
DKPA200200844 2002-05-31
PCT/DK2003/000342 WO2003101458A1 (en) 2002-05-31 2003-05-22 A combination of an nmda-antagonist and acetylcholine esterase inhibitors for the treatment of alzheimer's disease

Publications (2)

Publication Number Publication Date
EA200401617A1 true EA200401617A1 (ru) 2005-06-30
EA007632B1 EA007632B1 (ru) 2006-12-29

Family

ID=28051666

Family Applications (1)

Application Number Title Priority Date Filing Date
EA200401617A EA007632B1 (ru) 2002-05-31 2003-05-22 Комбинация nmda-антагониста и ингибиторов ацетилхолинэстеразы для лечения болезни альцгеймера

Country Status (9)

Country Link
KR (1) KR101016927B1 (ru)
CN (1) CN1655793A (ru)
AR (1) AR040121A1 (ru)
CA (1) CA2426492C (ru)
EA (1) EA007632B1 (ru)
IS (1) IS7558A (ru)
PE (1) PE20040623A1 (ru)
UA (1) UA82480C2 (ru)
ZA (1) ZA200409147B (ru)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA107653U (uk) 2012-10-01 2016-06-24 Общєство С Огранічєнной Отвєтствєнностью "Валєнта-Інтєллєкт" Композиція лікарських засобів для лікування та профілактики поведінкових, психічних та когнітивних розладів
CN105294450B (zh) * 2014-05-29 2024-05-17 广州喜鹊医药有限公司 具有神经保护作用的金刚烷胺硝酸酯化合物及其制备和医药应用
WO2018062941A1 (ko) * 2016-09-30 2018-04-05 주식회사 바이오파마티스 도네페질 또는 그의 약학적으로 허용 가능한 염 및 메만틴 또는 그의 약학적으로 허용 가능한 염을 함유하는 치매 및 인지기능 장애 예방 또는 치료용 약학 조성물 및 이의 제조방법
KR20210072569A (ko) 2019-12-09 2021-06-17 주식회사 종근당 도네페질 및 메만틴을 포함하는 복합 제제

Also Published As

Publication number Publication date
CN1655793A (zh) 2005-08-17
UA82480C2 (ru) 2008-04-25
AR040121A1 (es) 2005-03-16
IS7558A (is) 2004-11-26
ZA200409147B (en) 2006-06-28
EA007632B1 (ru) 2006-12-29
KR20050024296A (ko) 2005-03-10
CA2426492A1 (en) 2003-09-16
KR101016927B1 (ko) 2011-02-28
PE20040623A1 (es) 2004-09-11
CA2426492C (en) 2006-10-03

Similar Documents

Publication Publication Date Title
NO20045434L (no) En kombinasjon av en NMDA-antagonist og acetylkolinesteraseinhibitorer for behandlingen av Alzheimers sykdom
BG66085B1 (bg) Фенилаланинови производни
EA200200571A1 (ru) Новая композиция и ее применение
DE69925133D1 (de) Pyrrolobenzodiazepine
CY1106697T1 (el) Ν-υποκατεστημενες υδρομορφονες και η χρηση αυτων
EA200401019A1 (ru) Дозированная лекарственная форма для перорального применения, содержащая ингибитор pde 4 в качестве действующего вещества и поливинилпирролидон в качестве вспомогательного вещества
IL165262A (en) Kinase inhibitors and pharmaceutical compositions containing them
ECSP055701A (es) Nuevos derivados de pirimidinamida y el uso de los mismos
EA200300183A1 (ru) Новое сочетание агониста (5-th2) и антагониста (5-ht6) серотонина в качестве фармацевтической композиции
MXPA05007609A (es) Antagonista de un receptor sensible al calcio.
EA200301223A1 (ru) Лекарственные формы окскарбазепина
DE60302157D1 (de) Opioidrezeptorantagonisten
EA200401227A1 (ru) Система доставки лекарства с контролируемым высвобождением, включающая правастатин
EA200001039A1 (ru) Кальцилитические соединения
EE200100104A (et) 5-HT4 agonisti või antagonisti uus peroraalne ravimvorm
DK1458393T3 (da) Substituerede diketopiperaziner som oxytocinantagonister
EE200100520A (et) N-(2-fenüül-4-aminobutüül)-1-naftamiidid neurokiniin-1-retseptori antagonistidena
DE60134735D1 (de) Neue neurokinin-antagonisten zum gebrauch als arzneimittel
EA200100089A1 (ru) Предотвращение рецидива мигрени
EA200401137A1 (ru) Фармацевтическая композиция, содержащая ингибитор pde4 или pde3/4 и антагонист гистаминового рецептора
EE200300129A (et) Distamütsiini alfa-halogenoakrüloüülderivaadi kasutamine
DE69917005D1 (de) Substituierte pyrrolobenzimidazolderivate zur entzündungshemmung
ATE330599T1 (de) Verwendung von angiotensin ii rezeptorantagonisten zur behandlung von akutem myokardischen infarkt
EA200401617A1 (ru) Комбинация nmda-антагониста и ингибиторов ацетилхолинэстеразы для лечения болезни альцгеймера
EA200100098A1 (ru) Соли пароксетина

Legal Events

Date Code Title Description
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): AM AZ KZ KG MD TJ TM

MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): BY RU